Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Sees Significant Increase in Short Interest

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 33,900 shares, a growth of 1,312.5% from the December 15th total of 2,400 shares. Based on an average trading volume of 1,090,000 shares, the short-interest ratio is presently 0.0 days. Approximately 1.2% of the shares of the company are sold short.

Shuttle Pharmaceuticals Stock Down 2.1 %

Shuttle Pharmaceuticals stock traded down $0.02 during midday trading on Tuesday, hitting $0.88. The stock had a trading volume of 45,843 shares, compared to its average volume of 72,365. Shuttle Pharmaceuticals has a 52-week low of $0.58 and a 52-week high of $4.95. The stock has a fifty day moving average of $0.87. The stock has a market capitalization of $3.23 million, a P/E ratio of -0.21 and a beta of -1.74.

Shuttle Pharmaceuticals Company Profile

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .